These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2573565)

  • 21. Management of gastro-oesophageal reflux disease. Are there alternatives to omeprazole?
    Meuwissen SG; Klinkenberg-Knol EC
    Digestion; 1989; 44 Suppl 1():54-62. PubMed ID: 2575062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medical treatment of gastroesophageal reflux by H2 receptor antagonists].
    Scarpignato C; Bruley des Varannes S
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S78-89. PubMed ID: 10078436
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cough and gastro-oesophageal reflux.
    Ing AJ; Ngu MC
    Lancet; 1999 Mar; 353(9157):944-6. PubMed ID: 10459900
    [No Abstract]   [Full Text] [Related]  

  • 25. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
    Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies.
    Tran T; Lowry AM; El-Serag HB
    Aliment Pharmacol Ther; 2007 Jan; 25(2):143-53. PubMed ID: 17229239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.
    Bell NJ; Hunt RH
    Gut; 1992 Jan; 33(1):118-24. PubMed ID: 1346769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.
    Gawrieh S; Shaker R
    Drugs Aging; 2003; 20(7):509-16. PubMed ID: 12749748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases?
    Holt S
    Drugs; 1994 Jan; 47(1):1-11. PubMed ID: 7510616
    [No Abstract]   [Full Text] [Related]  

  • 32. [On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].
    Lamers CB
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1630-2. PubMed ID: 12966627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy and drugs used in gastro-oesophageal reflux.
    Prescrire Int; 2015 Dec; 24(166):297-9. PubMed ID: 26788579
    [No Abstract]   [Full Text] [Related]  

  • 35. Treating gastroesophageal reflux disease.
    Long K; Long R
    Nurse Pract Forum; 1994 Jun; 5(2):63-4. PubMed ID: 7912126
    [No Abstract]   [Full Text] [Related]  

  • 36. Gastro-oesophageal reflux.
    Lee MG
    West Indian Med J; 1994 Mar; 43(1):9-11. PubMed ID: 7913565
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms.
    Tougas G; Armstrong D
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():51B-54B. PubMed ID: 9347179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary gastro-oesophageal reflux disease and irritable oesophagus syndrome as causes of recurrent abdominal pain in children.
    Corrado G; Cavaliere M; Frandina G; Rea P; Pacchiarotti C; Capocaccia P; Cardi E
    Ital J Gastroenterol; 1996; 28(8):462-9. PubMed ID: 9032590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease.
    Inamori M; Iida H; Hosono K; Endo H; Sakamoto Y; Takahashi H; Koide T; Tokoro C; Goto A; Abe Y; Hiratsuka N; Nakajima A; Fujita M
    Hepatogastroenterology; 2010; 57(104):1430-4. PubMed ID: 21443098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.